Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.35 USD | +0.41% | +15.02% | +13.08% |
04-24 | Avid Bioservices, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended January 31, 2024 | CI |
04-19 | North American Morning Briefing : Stock Futures -2- | DJ |
Sales 2024 * | 139M 11.1B | Sales 2025 * | 166M 13.25B | Capitalization | 467M 37.35B |
---|---|---|---|---|---|
Net income 2024 * | -16M -1.28B | Net income 2025 * | -4M -320M | EV / Sales 2024 * | 3.37 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.82 x |
P/E ratio 2024 * |
-28.6
x | P/E ratio 2025 * |
-118
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.9% |
Latest transcript on Avid Bioservices, Inc.
1 day | +0.41% | ||
1 week | +15.02% | ||
Current month | +9.70% | ||
1 month | +5.30% | ||
3 months | +8.57% | ||
6 months | +19.12% | ||
Current year | +13.08% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 29/07/20 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 31/07/18 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/98 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 59 | 26/11/17 |
Joseph Carleone
CHM | Chairman | 78 | 26/11/17 |
Catherine Mackey
BRD | Director/Board Member | 68 | 24/07/19 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 7.35 | +0.41% | 1,268,426 |
25/04/24 | 7.32 | +7.17% | 1,916,082 |
24/04/24 | 6.83 | +2.25% | 1,442,149 |
23/04/24 | 6.68 | +4.21% | 702,786 |
22/04/24 | 6.41 | +0.31% | 511,100 |
Delayed Quote Nasdaq, April 26, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.08% | 467M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.36B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- CDMO Stock